35 results on '"Hamilton, Iona"'
Search Results
2. Relationship between inferior frontal sulcal hyperintensities on brain MRI, ageing and cerebral small vessel disease
3. Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease
4. Imaging neurovascular, endothelial and structural integrity in preparation to treat small vessel diseases. The INVESTIGATE-SVDs study protocol. Part of the SVDs@Target project
5. Structural Brain MRI Trait Polygenic Score Prediction of Cognitive Abilities
6. Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial
7. Rose revisited : an analysis of pupils' opinions on the relevance of science education
8. Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.
9. Intracranial hemodynamic relationships in patients with cerebral small vessel disease
10. Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow
11. Effects of dietary micro nutrients on mechanisms associated with coronary heart disease
12. sj-pdf-1-jcb-10.1177_0271678X231173444 - Supplemental material for Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease
13. Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus
14. Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial
15. Imaging NeuroVascular, Endothelial and STructural Integrity in prepAration to TrEat Small Vessel Diseases. The INVESTIGATE-SVDs study Protocol
16. A Comparison of CVR Magnitude and Delay Assessed at 1.5 and 3T in Patients With Cerebral Small Vessel Disease
17. sj-pdf-2-eso-10.1177_2396987320929617 - Supplemental material for Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3
18. sj-pdf-1-eso-10.1177_2396987320929617 - Supplemental material for Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3
19. Marginal copper deficiency and atherosclerosis
20. Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3
21. Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3
22. Coupled changes in hippocampal structure and cognitive ability in later life
23. Intracranial functional haemodynamic relationships in patients with cerebral small vessel disease
24. Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow
25. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases
26. Coupled changes in hippocampal structure and cognitive ability in later life
27. Tolerability, Safety and Intermediary Pharmacological Effects of Cilostazol and Isosorbide Mononitrate, Alone and Combined, in Patients with Lacunar Ischaemic Stroke: The LACunar Intervention-1 (LACI-1) Trial
28. Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing
29. Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination
30. Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination
31. Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing.
32. The CMRF58 antibody recognizes a subset of CD123hi dendritic cells in allergen-challenged mucosa
33. Interactions between vitamins C and E in human subjects
34. The CMRF58 antibody recognizes a subset of CD123hidendritic cells in allergen‐challenged mucosa
35. The CMRF58 antibody recognizes a subset of CD123hi dendritic cells in allergen-challenged mucosa.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.